Clinical and Molecular Characterization of Disease Progression in Patients (Pts) With Low-Risk Myelofibrosis (MF) Enrolled in the MOST Study

Poster Presentation
© 2024 American Society of Hematology. All rights reserved.
Meeting: 2024 ASH® Annual Meeting
Indication: Polycythemia Vera (PV)
Presenter: Abdulraheem Yacoub, MD
Affiliation: University of Kansas Medical Center, Westwood, KS
Presentation Date: December 8, 2024
Abstract Number: 3136
Session: Session: 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster II
Related content: Polycythemia Vera (PV)
Poster Presentation
Abstract Number: 4546
Presenter: Pankit Vachhani, MD
Indication: Polycythemia Vera (PV)
Date Presented: December 9, 2024
Poster Presentation
Abstract Number: 3145
Presenter: Stephen T. Oh, MD, PhD
Indication: Polycythemia Vera (PV)
Date Presented: December 8, 2024

To access this content please accept the following declarations.

This content was selected by and is provided to you upon your unsolicited request courtesy of Novartis with permission of ASH®.